Taken together, these results suggest that therapeutic efficacy of dendritic cell-mediated vaccination approaches rely not only on effective antigen presentation, but also on highly effective anti-tumor T cell-mediated responses, which may not be influenced by STAT3 signaling. The gene discussed is STAT3; the disease is neoplasm.